Global To Conjoin Technological Advancements And Growth For The Remote Patient Monitoring Device Market

Remote patient monitoring is gaining popularity owing to the increase in chronic diseases and aging population. In the traditional healthcare setting all the data collected is lost as soon as the patient leaves the hospital and it is only found when a patient visits again.

However, remote patient monitoring device helps in collecting the data and share it even from a remote location outside hospital or clinic. The concept of telemedicine is also gaining momentum. It allows remote diagnosis and treatment of patients using a telecommunication device, this reduces cost substantially and offers care with comfort.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/3287 

Company Profiles

• Boston Scientific Corporation
• Koninklijke Philips N.V.
• Abbott Laboratories
• Nihon Kohden Corporation
• F. Hoffmann-La Roche Ltd.
• LifeWatch AG
• Medtronic
• St. Jude Medical

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/3287

The manufacturers of remote patient monitoring devices are also focusing on research and development activities and increasingly investing in the same. This is being done to improve the remote patient monitoring device currently offered and also decrease the high cost of devices.

Companies are also looking forward to come-up with a mobile application for remote patient monitoring, thereby, eliminating the need to spend on costly hardware. Manufacturers are developing cardiovascular and respiratory devices with increasing people suffering from various heart and breathing diseases. Hence, portable device monitoring heart rate and blood pressure. Sensor-based devices monitoring oxygen levels and to monitor medication usage are also being provided.

As per the report published by Persistence Market Research, the global remote patient monitoring device is likely to witness a significant growth during the forecast period 2017-2024. The global remote patient monitoring devices market is projected to surpass US$ 1000 Million revenue by the end of 2024.

Cardiac Monitors to Witness the Highest Sales in the Global Market   

Based on the product type, cardiac monitors are likely to witness the highest sales during 2017-2024. In terms of value, cardiac monitors are estimated to reach close to US$ 800 Million by 2024 end.

On the basis of indication, cardiac arrhythmia is expected to see a significant growth throughout the forecast period 2017-2024. Cardiac arrhythmia is projected to exceed US$ 300 Million revenue by the end of the forecast period. Meanwhile, ischemic diseases are also likely to see impressive growth in the global market for remote patient monitoring devices.

By the end user, hospitals followed by homecare setting are likely to experience a robust growth during 2017-2024. By the end of 2024, hospitals as the end users are projected to bring in nearly US$ 700 Million revenue.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/3287

North America to Lead the Global Remote Patient Monitoring Devices Market

North America is expected to remain dominant in the global market for remote patient monitoring devices during 2017-2024. By 2024 end, North America is likely to surpass US$ 500 Million in terms of revenue. The U.S. is one of the largest countries in the region for remote patient monitoring devices.

Technological advancements and the growing need for comfort is driving the demand for home-based monitoring devices. According to the report from American Heart Association, more than 80 million Americans have high blood pressure and more than 90 million Americans carry a diagnosis of cardiovascular diseases. Hence, the demand for remote patient monitoring devices is gaining traction in the region.

Top Reports of Persistence Market Research :-

Active Pharmaceutical Ingredient Market – Persistence Market Research predicts that the global active pharmaceutical ingredients market to exhibit a CAGR above 4% over the forecast period (2021-2031).

Opioids Market – According to the revised report published by Persistence Market Research, the global opioids market valued at US$ 40.5 Bn in 2020, and is predicted to expand at a CAGR of 3% over the forecast period (2021–2031).

Autogenous Vaccines Market – According to a revised report published by Persistence Market Research, the autogenous vaccines market was valued over US$ 116 Mn in 2020, and is predicted to witness an impressive CAGR of 5.5% over the forecast period (2021-2031).

About us:

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com